{"transactions":[{"id":686457,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":23225,"kind":"person","name":"Jahr Robert Charles","position":1,"cik":"0002076177","reported_name":"Jahr Robert Charles","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2026-08-15T00:57:45.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":151515,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The warrants were exercisable immediately upon issuance and expire five years from the date of issuance, on August 14, 2031."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 14, 2026, the reporting person acquired 151,515 shares of common stock and accompanying warrants to purchase 151,515 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant."}],"balance_after":151515,"derivative":{"exercise_price":1.1,"exercise_date":"2026-08-14","expiration_date":"2031-08-14","underlying":"Common Stock","underlying_shares":151515},"source":{"system":"sec-edgar","filing":"0001104659-26-097406","document":"tm2623340-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926097406/tm2623340-2_4seq1.xml","form_type":"4"}},{"id":686456,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":23225,"kind":"person","name":"Jahr Robert Charles","position":1,"cik":"0002076177","reported_name":"Jahr Robert Charles","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-15T00:57:45.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":151515,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 14, 2026, the reporting person acquired 151,515 shares of common stock and accompanying warrants to purchase 151,515 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant."}],"balance_after":151515,"source":{"system":"sec-edgar","filing":"0001104659-26-097406","document":"tm2623340-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926097406/tm2623340-2_4seq1.xml","form_type":"4"}},{"id":703926,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":23225,"kind":"person","name":"Jahr Robert Charles","position":1,"cik":"0002076177","reported_name":"Jahr Robert Charles","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-23T23:34:19.000Z","date":"2026-07-21","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted to Mr. Jahr on July 21, 2026, pursuant to the Issuer's 2024 Equity Incentive Plan and the Issuer's standard form of stock option agreement thereunder. The option vests and becomes exercisable in full on July 21, 2027, subject to Mr. Jahr's continuing service with the Issuer through such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.4304,"exercise_date":"2027-07-21","expiration_date":"2036-07-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001649989-26-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000164998926000006/primary_doc.xml","form_type":"4"}},{"id":1089888,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":23225,"kind":"person","name":"Jahr Robert Charles","position":1,"cik":"0002076177","reported_name":"Jahr Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-09T21:17:49.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on July 1, 2026, with the remaining shares vesting in 36 equal monthly installments over the following three (3) years, subject to the Reporting Person's Continuous Service to the Issuer through each such vesting date."}],"balance_after":800000,"derivative":{"exercise_price":1.58,"expiration_date":"2035-07-01","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001415889-25-019586","document":"form4-07092025_090745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000141588925019586/form4-07092025_090745.xml","form_type":"4"}}]}